CANDEL THERAPEUTICS INC. - COMMON STOCK
5.0400
22-11月-24 16:44:58
15 分の遅延
株式
+0.9050
+21.89%
本日の幅
4.1900 - 5.5700
ISIN
N/A
ソース
NASDAQ
-
Candel Therapeutics Receives FDA Fast Track Designation for CAN-2409 in Non-Small Cell Lung Cancer
17 4 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
30 3 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Candel Therapeutics to Participate in Guggenheim Healthcare Talks 2023 Oncology Day
01 2 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Candel Therapeutics to Participate in Upcoming B. Riley Oncology Conference
12 1 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
06 12 2022 16:26:35 提供 Nasdaq GlobeNewswire
-
Candel Therapeutics to Host Virtual R&D Day on December 6, 2022
29 11 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
Candel Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
10 11 2022 08:00:03 提供 Nasdaq GlobeNewswire
-
Candel Therapeutics Announces Upcoming Clinical Data Presentations at SITC and SNO
07 11 2022 08:00:02 提供 Nasdaq GlobeNewswire
-
Candel Therapeutics Upcoming Investor Conference Participation for November
01 11 2022 08:00:03 提供 Nasdaq GlobeNewswire
-
15 9 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
Candel Therapeutics Announces Two Executive Leadership Appointments
07 9 2022 08:00:02 提供 Nasdaq GlobeNewswire
-
Candel Therapeutics Upcoming Investor Conference Participation
06 9 2022 08:00:02 提供 Nasdaq GlobeNewswire
-
Candel Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
05 8 2022 08:00:00 提供 Nasdaq GlobeNewswire
-
Candel Therapeutics to Present at the H.C. Wainwright Annual Global Investment Conference
18 5 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
Candel Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate Highlights
12 5 2022 08:00:02 提供 Nasdaq GlobeNewswire
-
27 4 2022 16:00:00 提供 Nasdaq GlobeNewswire